Brokerages Reassess Canadian Companies With Mixed Ratings
Brokerages Reassess Canadian Companies With Mixed Ratings
Anonymous
Key Points
1
Rogers’ U.S.-listed analyst split consists of five buy ratings, three holds and one sell; individual views included Raymond James’ “outperform,” Barclays’ “equal weight” after lowering its target from $37 to $36, and TD Securities’ reiterated “buy.”
2
Rogers is Canada’s largest wireless provider, with more than 10 million subscribers—about one-third of the Canadian market. Wireless generated 60% of company sales in 2021, while cable contributes about one-quarter and provides internet, television and landline services.
3
For Rogers’ Canadian-listed shares, analyst targets ranged from C$57.50 to C$68.00: TD raised its target to C$65, Raymond James set C$68, and Desjardins issued a more cautious C$58 target with a hold rating.
4
IceCure’s latest filing showed that Jane Street Group acquired 109,638 shares, valued at approximately $67,000, giving the firm a 0.16% stake; institutional investors and hedge funds collectively owned 0.62% of the stock.
5
Royal Bank of Canada shares opened at $205.94, with a 12-month trading range of $143.13 to $218.57; the bank’s market capitalization was reported at $285.56 billion and its price-to-earnings ratio at 18.02.
Canadian brokerages are sending mixed but cautiously optimistic signals about major domestic companies. Rogers Communications received a "Moderate Buy" consensus from analysts tracking its Canadian-listed shares with an average price target of C$59, while the U.S.-listed version carries a "Hold" rating averaging $36. Analyst Reports show Rogers beat quarterly expectations with $0.83 earnings per share on $3.95 billion in revenue, up 7.6% year over year. Royal Bank of Canada earned stronger backing with a "Moderate Buy" consensus and a $225 average 12-month target, though smaller companies like IceCure Medical face sharply divided analyst opinion.
Rogers Shows Strength Despite Mixed U.S. Ratings
Rogers Communications delivered better-than-expected quarterly results that impressed some but not all analysts. The company reported $0.83 per share in earnings on $3.95 billion in revenue, representing 7.6% year-over-year growth Analyst Reports. On U.S.-listed shares, five analysts assigned buy ratings while three issued holds and one sell, creating the "Hold" consensus with a $36 target. Raymond James rated the stock "outperform," but Barclays downgraded its view to "equal weight" after cutting its target from $37 to $36.
Canadian Shares Get Stronger Analyst Support
Rogers' Canadian-listed shares command more bullish views than their U.S. counterparts. Analysts tracking the Canadian version set price targets ranging from C$57.50 to C$68.00, with TD Securities raising its target to C$65 and Raymond James setting C$68.00 Analyst Reports. Desjardins took a more cautious stance, issuing a C$58 target paired with a hold rating. The "Moderate Buy" consensus reflects Rogers' dominant market position: the company controls about one-third of Canada's 10 million wireless subscribers and generated 60% of sales from wireless operations in 2021.
Royal Bank Commands Strong Analyst Consensus
Royal Bank of Canada commands stronger analyst support than Rogers, with fourteen analysts assigning a "Moderate Buy" consensus and an average 12-month price target of $225 Analyst Reports. Eight analysts issued buy ratings while one assigned a strong buy, signaling solid conviction among RBC watchers. The bank's current valuation metrics show strength: shares traded at $205.94 with a market capitalization of $285.56 billion and a price-to-earnings ratio of 18.02, placing it near the high end of its 12-month trading range of $143.13 to $218.57.
IceCure Medical Faces Sharply Divided Analyst Camp
IceCure Medical received a "Hold" consensus despite sharply split analyst opinions between buy and sell ratings, reflecting deep uncertainty about the company's future. The medical device maker reported a troubling quarterly loss of $1.60 per share on just $0.91 million in revenue Analyst Reports, with expectations for larger full-year losses ahead. Institutional investors have shown modest interest: Jane Street Group acquired 109,638 shares valued at approximately $67,000, giving the firm a 0.16% stake Analyst Reports. Institutional and hedge fund ownership totals only 0.62% of the stock, suggesting limited institutional confidence.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
17
Articles
17
Reach
34
A
AnonymousAuthor
